Patrick R. Coyle
Chief Financial Navigator™ | GTN Thought Leader & Commercialization Strategist
Patrick R. Coyle is a life sciences executive, GTN thought leader, finance strategist, and commercialization transformation advisor with more than 25 years of experience helping pharmaceutical manufacturers improve patient access, optimize channel performance, and strengthen enterprise profitability.
From global product launches and GTN transformation initiatives to commercialization strategy and healthcare revenue intelligence, Patrick has spent his career connecting patient journey outcomes with financial performance.
Healthcare has never had more organizations working to improve patient outcomes. Yet it has also never been more fragmented.
Our mission: build a trusted community where every stakeholder learns from one another and collaborates on solutions that improve the patient journey.
Patients and profitability are not competing priorities. Sustainable innovation depends on both.
The Ecosystem
Patients & Caregivers
Lived experience. Real-world barriers.
Patient Advocacy Orgs
Amplify patient voices.
Healthcare Providers
Clinical insight. Workflow reality.
Pharma Manufacturers
Patient-centric commercialization & affordability.
Tech & Service Providers
Transparency. Efficiency. Innovation.
Cross-Functional Teams
NextGen GTN™
Education & executive workshops for cross-functional alignment.
Novus Proximus LLC
Turns ideas into channel strategy & transformation.
My career has been shaped by a commitment to both: building financially sound organizations that deliver life-changing therapies to the patients who need them most.
My Bayer Journey: Finance Partner to Innovation (2008–2016)
Supporting Alpha Radium-223 (Xofigo®) from Clinical Development Through Global Commercialization
Clinical Development Finance
Phase 2b Development- Trial financial planning
- Investment decisions
Pivotal Trial Finance Partner
Phase 3 Development- Phase 3 program support
- Risk-adjusted valuation
Launch Readiness Finance
US Launch Preparation- Market access planning
- Revenue forecasting
Global Commercialization Finance
Global Launch Sequencing- Launch prioritization
- Global forecasting
Redesigning the Patient Journey.
Improving Outcomes. Changing Lives.
Eisai | Lenvima®
JOURNEY
Two TKIs. One Mission.
From Nexavar® to Lenvima®
What 25 Years Taught Me About Patients and Profitability
Every Prescription Begins With Hope.
A provider writes a prescription believing it will help a patient. A patient leaves the office believing treatment is on the way.
Yet every year, millions of prescriptions never become therapy.
For more than twenty-five years, I've worked at the intersection of pharmaceutical finance, patient access, commercialization, and operational strategy — and I've seen the same reality repeatedly:
Patients are lost long before therapy begins.
Manufacturers struggle to understand where profitability is leaking across increasingly complex commercialization models. These are not separate problems — they are two sides of the same system.
Patients + Profitability™ was created to help organizations understand both.
That is the work. That is the mission.
That is Patients + Profitability™.
What I Learned
Partnerships Matter
Support Improves Persistence
Finance Can Quantify Impact
Architecting Strategic Financial Advantage
Change Agent
Driving structural evolution to adapt your finance organization to shifting market realities.
Sovereign Guardian
Meticulous stewardship of capital and risk to ensure long-term clinical and fiscal sustainability.
Financial Narrator
Translating complex financial data into compelling stories that win board and investor confidence.
Business Partner
Aligning finance operations with R&D and Commercial goals for unified strategic execution.
Executive Facilitator
Streamlining decision-making processes across global executive teams and stakeholders.
Strategic Mentor
Cultivating the next generation of finance leaders through structured executive training.
Continue Exploring Patients + Profitability™
Industry Conversations & Original Insights
Webinars, panel discussions, speaking events, and publications on GTN, patient access, and commercialization.
Explore Thought LeadershipWhy Pharma Funds Access—But Doesn't Control It
A CFO's view of the "in-between" where margin is won or lost — connecting pricing, access, contracting, and GTN.
Download the EbookA Resource Hub Built for Deep Dives
Browse insights, frameworks, and media organized by topic and format — all in one place.
Browse the Library







